Biogen's progressive vision loss drug fails in late-stage clinical trials
May 14, 2021 at 11:06 AM EDT
A gene therapy for progressive vision loss developed by Biogen Inc. has failed in late-stage clinical trials, the Cambridge biotech said Friday.
